PLx Pharma Inc.
PLXP · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $189 | $54 | $39 | $13 |
| - Cash | $69 | $22 | $14 | $14 |
| + Debt | $0 | $1 | $4 | $7 |
| Enterprise Value | $120 | $32 | $29 | $6 |
| Revenue | $8 | $0 | $1 | $1 |
| % Growth | 26,873.4% | -94.6% | -24.9% | – |
| Gross Profit | $3 | $0 | $1 | $1 |
| % Margin | 41.5% | 100% | 100% | 100% |
| EBITDA | -$35 | -$14 | -$14 | $2 |
| % Margin | -429.3% | -47,607.9% | -2,440% | 297.9% |
| Net Income | -$51 | -$15 | -$21 | $1 |
| % Margin | -626.9% | -49,631.9% | -3,773.7% | 119% |
| EPS Diluted | -2.18 | -1.55 | -2.39 | 0.1 |
| % Growth | -40.6% | 35.1% | -2,490% | – |
| Operating Cash Flow | -$32 | -$12 | -$13 | -$9 |
| Capital Expenditures | $0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$32 | -$12 | -$13 | -$10 |